# Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis

> **NCT03471611** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 21 (actual)

## Conditions studied

- Atherosclerosis, Coronary

## Interventions

- **DRUG:** Autologous CD34+ Cells
- **DRUG:** Granulocyte Colony-Stimulating Factor (G-CSF)

## Key facts

- **NCT ID:** NCT03471611
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-15
- **Primary completion:** 2020-10-02
- **Final completion:** 2020-10-02
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03471611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03471611, "Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03471611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*